PRMT5 IS A POTENTIAL THERAPEUTIC VULNERABILITY IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Ph.D
Saved in:
Main Author: | MALINI RETHNAM |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/213937 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
INVESTIGATING THE EFFECT OF PRMT INHIBITORS ON MYELOID LEUKEMIAS WITH SPLICEOSOMAL GENE MUTATIONS
by: FONG JIA YI
Published: (2019) -
CHARACTERIZATIONS OF METHYLTRANSFERASE-LIKE PROTEIN 2 IN RNA MODIFICATION
by: XU LUANG
Published: (2016) -
Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
by: Kubota, S., et al.
Published: (2021) -
Characterization of The Role of Protein Arginine Methyltransferase 5 (PRMT5) in Mammalian Development
by: MARCO BEZZI
Published: (2014) -
DISSECTING THE ROLE OF EPIGENETIC MODIFIERS IN LEUKEMIA
by: LUCA PIGNATA
Published: (2021)